Daniel Wiederkehr
- Cardiology and Cardiovascular Medicine top 5%
- Internal Medicine top 2%
- Economics and Econometrics top 10%
- Epidemiology
- Rheumatology
- Co-authors
- Dinara MakenbaevaAlpesh AminJohn GrahamJay LinYonghua JingSteve DeitelzweigDana P. GoldmanYounos Abdulsattar
- Topics
- Atrial Fibrillation Management and Outcomes (22 papers)Health Systems, Economic Evaluations, Quality of Life (13 papers)Pharmaceutical Economics and Policy (7 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Daniel Wiederkehr
33 papers receiving 587 citations
Peers
Comparison fields: 5 of 61
- Cardiology and Cardiovascular Medicine 466
- Internal Medicine 194
- Economics and Econometrics 96
- Epidemiology 79
- Rheumatology 45
Countries citing papers authored by Daniel Wiederkehr
This map shows the geographic impact of Daniel Wiederkehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wiederkehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wiederkehr more than expected).
Fields of papers citing papers by Daniel Wiederkehr
This network shows the impact of papers produced by Daniel Wiederkehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wiederkehr. The network helps show where Daniel Wiederkehr may publish in the future.
Co-authorship network of co-authors of Daniel Wiederkehr
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wiederkehr. A scholar is included among the top collaborators of Daniel Wiederkehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wiederkehr. Daniel Wiederkehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 114 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 61 | |
| 5 | 33 | |
| 6 | 1 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 53 | |
| 10 | 1 | |
| 11 | 33 | |
| 12 | 17 | |
| 13 | 10 | |
| 14 | 8 | |
| 15 | 7 | |
| 16 | 9 | |
| 17 | 2 | |
| 18 | 80 | |
| 19 | 4 | |
| 20 | 8 |
About Daniel Wiederkehr
Daniel Wiederkehr is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Economics and Econometrics, having authored 33 papers that have together received 601 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (22 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Pharmaceutical Economics and Policy (7 papers). The work is most often cited by research in Internal Medicine (194 citations), Cardiology and Cardiovascular Medicine (466 citations) and Family Practice (25 citations). Daniel Wiederkehr has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Dinara Makenbaeva, Alpesh Amin, John Graham, Jay Lin, Yonghua Jing, Steve Deitelzweig, Dana P. Goldman, Younos Abdulsattar, Mintu P. Turakhia and Jason Shafrin. Their work appears in journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.